Related Experiment Video
Updated: May 9, 2026

Development and Validation of a Methodology for Establishing Obese Rat Models with Typical Fatty Pancreas
Published on: November 11, 2025
Obesity and insulin resistance induce early development of diastolic dysfunction in young female mice fed a Western
Camila Manrique1, Vincent G DeMarco, Annayya R Aroor
1MD, Professor of Medicine and Medical Pharmacology and Physiology, University of Missouri, D109 Diabetes Center Health Sciences Center, One Hospital Drive, Columbia, Missouri 65212. sowersj@health.missouri.edu.
Insights
A Western diet causes diastolic dysfunction, an early sign of heart failure, in female mice due to insulin resistance and increased cardiac stiffness. Male mice did not develop this dysfunction.
Area of Science:
- Cardiovascular physiology
- Metabolic disease research
- Sex differences in disease
Background:
- Cardiovascular disease (CVD) is a leading cause of death, particularly in individuals with diabetes.
- Women lose cardiovascular protection postmenopause and with diabetes, with heart failure and diastolic dysfunction being key concerns.
- Insulin resistance and obesity exacerbate heart failure risk in females.
Purpose of the Study:
- To investigate the mechanisms underlying diastolic dysfunction in insulin-resistant female mice.
- To compare the cardiac effects of a Western diet (WD) in young female versus male mice.
Main Methods:
- Eight weeks of a high-fructose/high-fat WD was administered to young female and male C57BL6/J mice.
- Insulin sensitivity was assessed using hyperinsulinemic-euglycemic clamps.
- Cardiac structure and function were evaluated via two-dimensional echocardiography and electron microscopy.
Main Results:
- Both sexes developed systemic insulin resistance after WD exposure.
- Only female mice exhibited diastolic dysfunction, characterized by increased collagen 1, oxidative stress, and altered mitochondria.
- Higher baseline aldosterone levels in females, independent of WD, were observed.
Conclusions:
- A Western diet predisposes females to early diastolic heart failure, independent of overall insulin resistance.
- Elevated aldosterone in females may interact with insulin resistance to promote myocardial stiffness and diastolic dysfunction under overnutrition.
Abstract:
Cardiovascular disease (CVD), including heart failure, constitutes the main source of morbidity and mortality in men and women with diabetes. Although healthy young women are protected against CVD, postmenopausal and diabetic women lose this CVD protection. Obesity, insulin resistance, and diabetes promote heart failure in females, and diastolic dysfunction is the earliest manifestation of this heart failure. To examine the mechanisms promoting diastolic dysfunction in insulin-resistant females, this investigation evaluated the impact of 8 weeks of a high-fructose/high-fat Western diet (WD) on insulin sensitivity and cardiac structure and function in young C57BL6/J female versus male mice. Insulin sensitivity was determined by hyperinsulinemic-euglycemic clamps and two-dimensional echocardiograms were used to evaluate cardiac function. Both males and females developed systemic insulin resistance after 8 weeks of a WD. However, only the females developed diastolic dysfunction. The diastolic dysfunction promoted by the WD was accompanied by increases in collagen 1, a marker of stiffness, increased oxidative stress, reduced insulin metabolic signaling, and increased mitochondria and cardiac microvascular alterations as determined by electron microscopy. Aldosterone (a promoter of cardiac stiffness) levels were higher in females compared with males but were not affected by the WD in either gender. These data suggest a predisposition toward developing early diastolic heart failure in females exposed to a WD. These data are consistent with the notion that higher aldosterone levels, in concert with insulin resistance, may promote myocardial stiffness and diastolic dysfunction in response to overnutrition in females.
Related Concept Videos
Type II Diabetes I: Introduction
Type II Diabetes II: Pathophysiology
Obesity

